Dr. Hudis Discusses Obesity as a Modifiable Risk Factor

Video

In Partnership With:

Clifford A. Hudis, MD, ASCO President-Elect and chief of the Breast Cancer Medicine Service and attending physician at Memorial Sloan-Kettering Cancer Center, discusses obesity as a modifiable risk factor for cancer.

Clifford A. Hudis, MD, ASCO President-Elect and chief of the Breast Cancer Medicine Service and attending physician at Memorial Sloan-Kettering Cancer Center, discusses obesity as a modifiable risk factor for cancer.

As president-elect, Hudis says that ASCO will begin to tackle the growing problem of obesity and its relationship to several common tumors: breast, high-grade prostate, colon, non-Hodgkin lymphoma, and others. There is a substantial amount of evidence that obesity is associated with higher rates of these tumors and worse outcomes.

Hudis says that ASCO has the opportunity to explore the science behind this issue and translate it into action. The theme for his term as president relates to this: the obligation to help society confront obesity as a modifiable risk factor. It is now projected in the U.S. that obesity will replace tobacco as the leading modifiable risk factor for these cancers.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine